Hemovigilance in developing countries

被引:10
|
作者
Ayob, Yasmin [1 ]
机构
[1] Natl Blood Ctr, Kuala Lumpur, Malaysia
关键词
Hemovigilance; Developing countries; Transfusion; Surveillance; BLOOD SAFETY; TRANSFUSION; HAEMOVIGILANCE;
D O I
10.1016/j.biologicals.2009.10.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Hemovigilance like quality systems and audits has become an integral part of the Blood Transfusion Service (BTS) in the developed world and has contributed greatly to the development of the blood service. However developing countries are still grappling with donor recruitment and efforts towards sufficiency and safety of the blood supply. In these countries the BTS is generally fragmented and a national hemovigilance program would be difficult to implement. However a few developing countries have an effective and sustainable blood program that can deliver equitable, safe and sufficient blood supply to the nation. Different models of hemovigilance program have been introduced with variable success There are deficiencies but the data collected provided important information that can be presented to the health authorities for effective interventions Hemovigilance program modeled from developed countries require expertise and resources that are not available in many developing countries. Whatever resources that are available should be utilized to correct deficiencies that are already apparent and obvious Besides there are other tools that can be used to monitor the blood program in the developing countries depending on the need and the resources available. More importantly the data collected should be accurate and are used and taken into consideration in formulating guidelines, standards and policies and to affect appropriate interventions. Any surveillance program should be introduced in a stepwise manner as the blood transfusion service develops. (C) 2009 The International Association for Biologicals Published by Elsevier Ltd All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 50 条
  • [21] Stillbirth in developing countries
    McClure, E. M.
    Nalubamba-Phiri, M.
    Goldenberg, R. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 94 (02) : 82 - 90
  • [22] Glaucoma in developing countries
    Thomas, Ravi
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2012, 60 (05) : 446 - 450
  • [23] Diabetes in developing countries
    Misra, Anoop
    Gopalan, Hema
    Jayawardena, Ranil
    Hills, Andrew P.
    Soares, Mario
    Reza-Albarran, Alfredo A.
    Ramaiya, Kaushik L.
    JOURNAL OF DIABETES, 2019, 11 (07) : 522 - 539
  • [24] Cryptosporidiosis in developing countries
    Snelling, William J.
    Xiao, Lihua
    Ortega-Pierres, Guadalupe
    Lowery, Colm J.
    Moore, John E.
    Rao, Juluri R.
    Smyth, Stephen
    Millar, B. Cherie
    Rooney, Paul J.
    Matsuda, Motoo
    Kenny, Fiona
    Xu, Jiru
    Dooley, James S. G.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2007, 1 (03): : 242 - 256
  • [25] The best blood product and its best use for each patient: An evolving role for hemovigilance?
    Tiberghien, Pierre
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2019, 26 (03) : 188 - 191
  • [26] FDI from Developing Countries to Developing Countries: Contributing at More Risky Location?
    Masron, Tajul Ariffin
    Abdullah, Hussin
    Amran, Azlan
    8TH INTERNATIONAL STRATEGIC MANAGEMENT CONFERENCE, 2012, 58 : 1212 - 1217
  • [27] Developing sustainable supply chains in developing countries
    Galal, Noha M.
    Moneim, Ahmed F. Abdul
    23RD CIRP CONFERENCE ON LIFE CYCLE ENGINEERING, 2016, 48 : 419 - 424
  • [28] Hypersensitivity transfusion reactions to fresh frozen plasma: a retrospective analysis of the French hemovigilance network
    Tacquard, Charles
    Andreu, Georges
    Meyer, Nicolas
    Carlier, Monique
    Py, Jean-Yves
    Drouet, Christian
    Bienvenu, Jacques
    Mertes, Paul Michel
    Boudjedir, Karim
    TRANSFUSION MEDICINE REVIEWS, 2022, 36 (02) : 77 - 81
  • [29] EPIDEMIOLOGIC SUPPORT OF HEMOVIGILANCE
    SALMI, LR
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1994, 1 (06) : 421 - 424
  • [30] How is national recipient hemovigilance conducted in the United States?
    Chung, Koo-Whang
    Harvey, Alexis
    Basavaraju, Sridhar V.
    Kuehnert, Matthew J.
    TRANSFUSION, 2015, 55 (04) : 703 - 707